• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有新型基因致病变异的菲律宾婴儿的鲁宾斯坦-泰比综合征

Rubinstein-Taybi Syndrome in a Filipino Infant with a Novel Gene Pathogenic Variant.

作者信息

Yumul Rhea Camille R, Chiong Mary Anne D

机构信息

Department of Pediatrics, University of Santo Tomas Hospital, España Boulevard, Manila, Philippines.

出版信息

Case Rep Genet. 2022 May 21;2022:3388879. doi: 10.1155/2022/3388879. eCollection 2022.

DOI:10.1155/2022/3388879
PMID:35637708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9148230/
Abstract

Rubinstein-Taybi syndrome (RSTS) is a rare genetic disorder characterized by dysmorphic facial features, broad thumbs and halluces, intellectual disability, and postnatal growth retardation. This report presents a male infant with microcephaly and characteristic facial features, namely, low anterior hairline, hirsutism, thin upper lip and micrognathia, broad thumbs and first toes, cryptorchidism, recurrent pneumonia, developmental delay, and growth retardation. Genetic testing showed a novel pathogenic variant in the gene which is consistent with the clinical diagnosis of RSTS.

摘要

鲁宾斯坦-泰比综合征(RSTS)是一种罕见的遗传性疾病,其特征为面部畸形、拇指和拇趾宽阔、智力残疾以及出生后生长发育迟缓。本报告介绍了一名患有小头畸形和特征性面部特征的男婴,具体表现为前额发际线低、多毛症、上唇薄和小颌畸形、拇指和第一趾宽阔、隐睾、反复肺炎、发育迟缓以及生长发育迟缓。基因检测显示该基因存在一种新的致病变异,这与RSTS的临床诊断相符。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9148230/343b00e3a34e/CRIG2022-3388879.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9148230/343b00e3a34e/CRIG2022-3388879.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9148230/343b00e3a34e/CRIG2022-3388879.001.jpg

相似文献

1
Rubinstein-Taybi Syndrome in a Filipino Infant with a Novel Gene Pathogenic Variant.一名患有新型基因致病变异的菲律宾婴儿的鲁宾斯坦-泰比综合征
Case Rep Genet. 2022 May 21;2022:3388879. doi: 10.1155/2022/3388879. eCollection 2022.
2
Clinical description and mutational profile of a Moroccan series of patients with Rubinstein Taybi syndrome.临床描述和突变谱的摩洛哥系列患者 Rubinstein-Taybi 综合征。
Afr Health Sci. 2021 Jun;21(2):960-967. doi: 10.4314/ahs.v21i2.58.
3
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.Rubinstein-Taybi 2 综合征伴新型 EP300 基因突变:临床与遗传学特征的深入研究。
BMC Med Genet. 2018 Mar 5;19(1):36. doi: 10.1186/s12881-018-0548-2.
4
Rubinstein-Taybi Syndrome鲁宾斯坦-泰比综合征
5
Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly.临床外显子组测序鉴定出 18 例中国 Rubinstein-Taybi 综合征患儿中 CREBBP 新变异,多指畸形发生率高。
Mol Genet Genomic Med. 2019 Dec;7(12):e1009. doi: 10.1002/mgg3.1009. Epub 2019 Oct 22.
6
Hyperinsulinism in an individual with an EP300 variant of Rubinstein-Taybi syndrome.个体患有 Rubinstein-Taybi 综合征的 EP300 变异,并发高胰岛素血症。
Am J Med Genet A. 2021 Apr;185(4):1251-1255. doi: 10.1002/ajmg.a.62085. Epub 2021 Jan 14.
7
CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype.无鲁宾斯坦-泰比综合征表型个体中的CREBBP突变
Am J Med Genet A. 2016 Oct;170(10):2681-93. doi: 10.1002/ajmg.a.37800. Epub 2016 Jun 17.
8
A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene.1例鲁宾斯坦-泰比综合征病例:CREBBP基因中的一种新型移码突变
Turk J Pediatr. 2017;59(5):601-603. doi: 10.24953/turkjped.2017.05.017.
9
New insights into genetic variant spectrum and genotype-phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP-positive patients.对 39 例 CREBBP 阳性患者的 Rubinstein-Taybi 综合征遗传变异谱及基因型-表型相关性的新认识。
Mol Genet Genomic Med. 2019 Nov;7(11):e972. doi: 10.1002/mgg3.972. Epub 2019 Sep 30.
10
Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report.一名沙特男孩患鲁宾斯坦-泰比综合征,具有独特特征且CREBBP和EP300基因均存在变异:病例报告
BMC Med Genet. 2019 Jan 11;20(1):12. doi: 10.1186/s12881-019-0747-5.

引用本文的文献

1
Challenges in Prenatal Ultrasound Diagnosis of Rubinstein-Taybi Syndrome: A Case Report and Comprehensive Literature Review.鲁宾斯坦-泰比综合征产前超声诊断的挑战:一例报告及文献综述
Int J Mol Sci. 2025 May 27;26(11):5142. doi: 10.3390/ijms26115142.

本文引用的文献

1
Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients.组蛋白去乙酰化酶抑制剂改善 Rubinstein-Taybi 综合征患者诱导多能干细胞神经元的形态缺陷和低兴奋性。
Int J Mol Sci. 2021 May 28;22(11):5777. doi: 10.3390/ijms22115777.
2
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein-Taybi Syndrome Patients.97 例 Rubinstein-Taybi 综合征患者队列中的免疫缺陷患病率。
J Clin Immunol. 2020 Aug;40(6):851-860. doi: 10.1007/s10875-020-00808-4. Epub 2020 Jun 27.
3
Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.
极罕见综合征:以鲁宾斯坦-泰比综合征为例。
J Pediatr Genet. 2015 Sep;4(3):177-86. doi: 10.1055/s-0035-1564571. Epub 2015 Sep 28.
4
Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders.《胎儿酒精谱系障碍诊断临床指南(更新版)》
Pediatrics. 2016 Aug;138(2). doi: 10.1542/peds.2015-4256. Epub 2016 Jul 27.
5
Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.鲁宾斯坦-泰比综合征:临床特征、遗传基础、诊断及治疗
Ital J Pediatr. 2015 Jan 20;41:4. doi: 10.1186/s13052-015-0110-1.
6
Growth charts for individuals with Rubinstein-Taybi syndrome.鲁宾斯坦-泰比综合征患者的生长图表。
Am J Med Genet A. 2014 Sep;164A(9):2300-9. doi: 10.1002/ajmg.a.36654. Epub 2014 Jul 2.
7
Epigenetic mechanisms of Rubinstein-Taybi syndrome.鲁宾斯坦-泰比综合征的表观遗传机制
Neuromolecular Med. 2014 Mar;16(1):16-24. doi: 10.1007/s12017-013-8285-3. Epub 2014 Jan 1.
8
Rubinstein-Taybi syndrome: clinical and molecular overview.鲁宾斯坦-泰比综合征:临床与分子概述
Expert Rev Mol Med. 2007 Aug 20;9(23):1-16. doi: 10.1017/S1462399407000415.
9
Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients.鲁宾斯坦-泰比综合征:意大利患者中CREBBP基因突变谱
BMC Med Genet. 2006 Oct 19;7:77. doi: 10.1186/1471-2350-7-77.
10
Rubinstein-Taybi syndrome: an immune deficiency as a cause for recurrent infections.鲁宾斯坦-泰比综合征:一种作为反复感染病因的免疫缺陷。
Allergy Asthma Proc. 2006 May-Jun;27(3):281-4. doi: 10.2500/aap.2006.27.2864.